| scholarly article | Q13442814 |
| P50 | author | Ernesto Canalis | Q56269284 |
| Stefano Zanotti | Q56269901 | ||
| Kristen Parker | Q117248443 | ||
| P2093 | author name string | Jian Q Feng | |
| Ernesto Canalis | |||
| P2860 | cites work | The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation | Q24292169 |
| Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes | Q24307538 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| HERP, a new primary target of Notch regulated by ligand binding | Q24550855 | ||
| Notch signaling controls multiple steps of pancreatic differentiation | Q24569636 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| The amazing osteocyte | Q24635849 | ||
| Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1 | Q24653515 | ||
| Localization of ADAM10 and Notch receptors in bone | Q28140604 | ||
| HES and HERP families: multiple effectors of the Notch signaling pathway | Q28205103 | ||
| Matrix-embedded cells control osteoclast formation | Q28247746 | ||
| Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 | ||
| Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain | Q28273268 | ||
| Direct regulation of intestinal fate by Notch | Q28507015 | ||
| HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments | Q28587806 | ||
| Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene | Q28776291 | ||
| Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 | ||
| Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. | Q30531794 | ||
| Notch and the skeleton | Q33627230 | ||
| RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development | Q33786247 | ||
| Update in new anabolic therapies for osteoporosis | Q33786824 | ||
| Marrow stromal stem cells | Q33947769 | ||
| Notch signaling: the core pathway and its posttranslational regulation | Q34017623 | ||
| Fine-tuning of the intracellular canonical Notch signaling pathway. | Q34245052 | ||
| Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. | Q34501252 | ||
| Regulation of bone mass by Wnt signaling | Q34576629 | ||
| More complicated than it looks: assembly of Notch pathway transcription complexes | Q34817647 | ||
| Bone morphogenetic proteins, their antagonists, and the skeleton | Q35109618 | ||
| Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. | Q35728669 | ||
| Genetic mouse models for bone studies--strengths and limitations | Q35902980 | ||
| Osteocyte RANKL: new insights into the control of bone remodeling | Q36253514 | ||
| Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells | Q36697983 | ||
| Notch inhibits osteoblast differentiation and causes osteopenia | Q36796561 | ||
| Notch signaling and its integration with other signaling mechanisms. | Q36804582 | ||
| Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. | Q36838533 | ||
| Mechanisms of anabolic therapies for osteoporosis | Q36924676 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Dimorphic effects of Notch signaling in bone homeostasis. | Q37165102 | ||
| Identification of differentially expressed genes between osteoblasts and osteocytes | Q37316190 | ||
| Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation | Q37339719 | ||
| Guidelines for assessment of bone microstructure in rodents using micro-computed tomography | Q37763651 | ||
| Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation | Q37958663 | ||
| Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. | Q38298134 | ||
| Effect of primary and secondary structure of oligodeoxyribonucleotides on the fluorescent properties of conjugated dyes | Q39600740 | ||
| Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore | Q39600850 | ||
| Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination | Q39717984 | ||
| DMP1-targeted Cre expression in odontoblasts and osteocytes | Q40154569 | ||
| On Bone-Forming Cells and Blood Vessels in Bone Development | Q41138377 | ||
| Regulation of type I collagen gene expression in bone | Q42472130 | ||
| Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice | Q42495164 | ||
| Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast | Q43434401 | ||
| Cortisol regulates the expression of Notch in osteoblasts | Q43956288 | ||
| One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength | Q46171552 | ||
| Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. | Q48723022 | ||
| Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. | Q50722204 | ||
| Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. | Q50790300 | ||
| NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. | Q50878030 | ||
| Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. | Q51009028 | ||
| Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. | Q52110147 | ||
| Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. | Q52125683 | ||
| Reciprocal temporospatial patterns of Msx2 and Osteocalcin gene expression during murine odontogenesis. | Q52188708 | ||
| Function of osteocytes in bone | Q72809732 | ||
| Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization | Q74742272 | ||
| Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction | Q80432871 | ||
| The fate of circulating osteoblasts | Q81738834 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoblast | Q917177 |
| P304 | page(s) | 623-634 | |
| P577 | publication date | 2012-12-28 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Osteoblast lineage-specific effects of notch activation in the skeleton | |
| P478 | volume | 154 |
| Q51092180 | An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice. |
| Q41409749 | Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing |
| Q36480304 | Canonical Notch activation in osteocytes causes osteopetrosis |
| Q49894511 | Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders |
| Q33802623 | Connective tissue growth factor is a target of notch signaling in cells of the osteoblastic lineage |
| Q37209043 | Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH. |
| Q34071113 | Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro |
| Q47963128 | Effects of Sex and Notch Signaling on the Osteocyte Cell Pool |
| Q37423382 | Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans |
| Q37428990 | Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women |
| Q88162688 | Glucocorticoids inhibit notch target gene expression in osteoblasts |
| Q47907947 | Hairy and Enhancer of Split-Related With YRPW Motif-Like (HeyL) Is Dispensable for Bone Remodeling in Mice |
| Q37048325 | Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice |
| Q36489227 | Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption |
| Q42682923 | Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab |
| Q34728226 | Hajdu-Cheney syndrome: a review |
| Q52653382 | Induction of the Hajdu-Cheney Syndrome Mutation in CD19 B Cells in Mice Alters B-Cell Allocation but Not Skeletal Homeostasis. |
| Q37227350 | Interleukin 6 mediates selected effects of Notch in chondrocytes |
| Q33850283 | Intermittent activation of notch signaling promotes bone formation |
| Q41576456 | Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice |
| Q35755193 | LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling |
| Q33835628 | Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling |
| Q99234123 | Mechanisms of bone development and repair |
| Q36613082 | MicroRNAs and Bone Regeneration |
| Q38768325 | MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis |
| Q38169117 | MicroRNAs regulate bone metabolism |
| Q90105303 | Modulation of Notch1 signaling regulates bone fracture healing |
| Q33680742 | Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome |
| Q64103459 | NOTCH Signaling Is Activated through Mechanical Strain in Human Bone Marrow-Derived Mesenchymal Stromal Cells |
| Q33983866 | Nemo-like kinase regulates postnatal skeletal homeostasis |
| Q36960089 | Notch Signaling and the Skeleton |
| Q89860460 | Notch Signaling in Skeletal Development, Homeostasis and Pathogenesis |
| Q34157487 | Notch activation as a driver of osteogenic sarcoma |
| Q49893022 | Notch expressed by osteocytes plays a critical role in mineralisation. |
| Q38092026 | Notch signaling and bone remodeling |
| Q28590415 | Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling |
| Q35848797 | Notch signaling in skeletal health and disease |
| Q37625991 | Notch signaling in skeletal stem cells |
| Q37675480 | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture |
| Q36357606 | Osteocytes and Skeletal Pathophysiology |
| Q30619950 | Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone |
| Q41874233 | Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice |
| Q42511931 | Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes |
| Q46470367 | Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates |
| Q37525433 | Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells |
| Q48311397 | Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome |
| Q36981367 | Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing |
| Q39287117 | TNF and Bone Remodeling |
| Q36649905 | The Dmp1-SOST Transgene Interacts With and Downregulates the Dmp1-Cre Transgene and the Rosa(Notch) Allele |
| Q64949054 | The lateral meningocele syndrome mutation causes marked osteopenia in mice. |
| Q38203927 | The role of notch signaling in bone marrow niche. |
| Q42139802 | Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2. |
| Q34660221 | Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice |
| Q35737544 | mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway |
Search more.